Evivo Scientific Publications

Evivo is the only clinically-proven baby probiotic of its kind. Evivo contains the good bacteria B. infantis, which fully utilizes breast milk to protect baby's gut from potentially harmful bacteria linked to higher risk of colic, eczema, allergies, diabetes, and obesity.

Article Bifidobacteria-mediated immune system imprinting early in life

Article Bifidobacteria-mediated immune system imprinting early in life

Article Bifidobacteria-mediated immune system imprinting early in life

A lack of bifidobacteria and/or their genes required for the utilization of human milk oligosaccharides from breast milk is associated with systemic inflammation and immune imbalance early in life.

Symptomatic relief from at-home use of activated Bifidobacterium infantis EVC001 probiotic in infants: results from a consumer survey on the effects on diaper rash, colic symptoms, and sleep

Symptomatic relief from at-home use of activated Bifidobacterium infantis EVC001

Symptomatic relief from at-home use of activated Bifidobacterium infantis EVC001 probiotic in infants: results from a consumer survey on the effects on diaper rash, colic symptoms, and sleep

Impact of Probiotic B. infantis EVC001 Feeding in Premature Infants

Probiotic B. infantis EVC001 Feeding in Premature Infants

Impact of Probiotic Bifidobacteria infantis EVC001 Feeding in Premature Infants on the Gut Microbiome, Nosocomially Acquired Antibiotic Resistance, and Enteric Inflammation

Study quantifies unprecedented reduction in enteric inflammation, diaper rash and antibiotic use via bene

Metagenomic insights of the infant microbiome community

Scientific Reports

Metagenomic insights of the infant microbiome community structure and function across multiple sites in the United States

The gut microbiome plays an important role in early life, protecting newborns from enteric pathogens, promoting immune system development and providing key functions

Comparative Genome Analysis of Bifidobacterium longum subsp. infantis

Nutrients Journal Article

Comparative Genome Analysis of Bifidobacterium longum subsp. infantis Strains Reveals Variation in Human Milk Oligosaccharide Utilization Genes among Commercial Probiotics

Provides evidence of the functional implications of genetic differences among B.

Colonization by B. infantis EVC001 modulates enteric inflammation

intestinal inflammation in infants

Colonization by Bifidobacteria infantis EVC001 modulates enteric inflammation in exclusively breastfed infants

A clinical study published in the journal Pediatric Research shows that colonizing infants with

​​​​​​​Evivo Clinical Study Summary

Evivo Clinical Study Results

Evivo Clinical Study Summary

12/6/2017 — The bacteria in Evivo, Bifidobacterium longum subsp. infantis (B. infantis) is the critically important bacteria in baby’s gut microbiome early in life.

Early-life gut microbiome modulation reduces the abundance of antibiotic-resistant bacteria

journal article on antibiotic-resistant bacteria

Early-life gut microbiome modulation reduces the abundance of antibiotic-resistant bacteria

Colonization of the gut of breastfed infants by a single strain of B. longum subsp. infantis had a profound impact on the fecal metagenome, including a reduction in ARGs.

New Study Reveals Activated B. Infantis EVC001 Reduces Colonic Mucin Degradation in Babies

Activated B. Infantis EVC001 Reduces Colonic Mucin Degradation in Babies

New Study Reveals Activated Bifidobacteria Infantis EVC001 Reduces Colonic Mucin Degradation in Babies

Study results showing that breastfed babies colonized by Bifidobacterium longum subsp. infantis EVC001 displayed significantly less evidence of mucin degrada

pH of Babies' Stool Indicates Loss of Critical Good Bacteria Summary

pH of Baby’s Stool Indicates Loss of Critical Good Bacteria

Alarming Increase In pH of Babies' Stool Indicates Loss of Critical Good Bacteria

A healthy gut microbiome is connected to everything from digestion to cognition to immunity and begins the day you are born.

Integrating the Ecosystem Services Framework to Define Dysbiosis of the Breastfed Infant Gut: The Role of B. infantis and Human Milk Oligosaccharides

Integrating the Ecosystem Services Framework to Define Dysbiosis of the Breastfed Infant Gut

Integrating the Ecosystem Services Framework to Define Dysbiosis of the Breastfed Infant Gut: The Role of Bifidobacteria infantis and Human Milk Oligosaccharides

Mounting evidence supports a connection between the composition of the infant gut microbiome and long-term health. 

Colonization Resistance in the Infant Gut: The Role of B. infantis in Reducing pH and Preventing Pathogen Growth

article thumbnail

Colonization Resistance in the Infant Gut: The Role of Bifidobacterium infantis in Reducing pH and Preventing Pathogen Growth

Infant Fecal pH Revealed as a Critical Indicator of Infant Gut Health and Resistance against Gut Pathogen Invasion

N-glycans from human milk glycoproteins are selectively released by an infant gut symbiont in vivo

Journal Article about N-glycans from Human Milk Glycoproteins

N-glycans from Human Milk Glycoproteins are Selectively Released by an Infant Gut Symbiont In Vivo

Bifidobacterium infantis has unique enzymes that allow it to utilize special carbohydrates attached to proteins found in both human breastmilk and infant formula, called

Colonization of breastfed infants by Bifidobacterium longum subsp. infantis EVC001 reduces virulence gene abundance

Colonization of breastfed infants by Bifidobacterium longum subsp. infantis EVC001 reduces virulence gene abundance

Colonization of breastfed infants by Bifidobacterium longum subsp.

Safety & Tolerability Summary

Evivo-Safety-and-Tolerability

Safety & Tolerability Summary

5/30/2017 — One key beneficial bacteria is designed by nature to live in babies’ gut, and thrive in the presence of human breast milk: Bifidobacterium (including B. infantis).